Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Eisai
Company Monitoring Page for Eisai
latest headlines for company on cafepharma
Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021
PR Newswire
Tue, 03/9/21 - 10:45 am
Tags:
Clarivate
,
Biogen
,
Eisai
,
aducanumab
,
UCB Pharma
,
bimekizumab
,
Relugolix
,
Pfizer
,
Takeda
,
Myovant
,
vericiguat
,
Bayer
,
Merck
Merck's Keytruda Plus Eisai's Lenvima Could Open New Standard of Care in Renal Cancer
BioSpace
Tue, 02/16/21 - 11:12 am
Tags:
Merck
,
ASCO GU
,
Keytruda
,
Eisai
,
Lenvima
,
renal cell carcinoma
FDA extends review period for Biogen's Alzheimer's drug
Reuters
Fri, 01/29/21 - 10:06 am
Tags:
Biogen
,
Eisai
,
FDA
,
aducanumab
,
Alzheimer's disease
Aducanumab tops 2021’s biggest potential launches
EP Vantage
Mon, 01/18/21 - 01:04 pm
Tags:
drug launches
,
Biogen
,
Eisai
,
aducanumab
,
efgartigimod
,
Argenx
,
Evrenzo
,
FibroGen
,
Astellas
,
AstraZeneca
,
Leqvio
,
Novartis
,
UCB Pharma
,
bimekizumab
,
Ascendis Pharma
,
Bluebird Bio
,
Bristol-Myers Squibb
,
ide-cel
,
liso-cel
,
AXS-05
,
Axsome Therapeutics
,
voclosporin
,
Aurinia
Could Keytruda/Lenvima Combo Help Treat Advanced Renal Cell Carcinoma?
BioSpace
Tue, 11/10/20 - 11:10 am
Tags:
Merck
,
Eisai
,
Keytruda
,
Lenvima
,
clinical trials
,
advanced renal cell carcinoma
ESMO: Where will Merck, Eisai take Keytruda-Lenvima next? Ovarian and colorectal cancer could be good options, data show
Fierce Pharma
Sun, 09/20/20 - 07:44 pm
Tags:
Merck
,
Eisai
,
Keytruda
,
Lenvima
,
ovarian cancer
,
colorectal cancer
Eisai is creating a new US corporate, R&D HQ in Roche’s old Nutley, NJ campus
Endpoints
Tue, 08/11/20 - 12:31 pm
Tags:
Eisai
,
Roche
,
R&D
,
New Jersey
Biogen nabs speedy FDA review for controversial Alzheimer’s drug
Fierce Biotech
Fri, 08/7/20 - 11:00 am
Tags:
Biogen
,
aducanumab
,
Eisai
,
FDA
,
Alzheimer's disease
,
priority review
Biogen and Eisai trial drug in asymptomatic Alzheimer’s disease
Pharmaforum
Tue, 07/14/20 - 10:31 am
Tags:
Biogen
,
Eisai
,
Alzheimer's disease
,
amyloid
,
BAN2401
,
clinical trials
Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan
Pharmaforum
Tue, 07/7/20 - 10:40 am
Tags:
Eisai
,
Dayvigo
,
Japan
,
insomnia
,
Merck
,
Belsomra
ASCO: Merck, Eisai pad case for liver cancer nod with Keytruda-Lenvima combo data
Fierce Pharma
Mon, 06/1/20 - 12:00 am
Tags:
Merck
,
Eisai
,
liver cancer
,
ASCO 2020
,
Keytrua
,
Lenvima
,
clinical trials
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharmaforum
Thu, 03/26/20 - 10:38 am
Tags:
JNJ
,
Novartis
,
Boehringer Ingelheim
,
Biomerieux
,
Eisai
,
Eli Lilly
,
Gilead Sciences
,
GSK
,
Merck
,
Merck KGaA
,
Pfizer
,
Sanofi
,
R&D
,
COVID-19
,
diagnostics
,
vaccines
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
Xconomy
Thu, 02/13/20 - 11:39 pm
Tags:
Eisai
,
lorcaserin
,
Belviq
,
cancer
,
FDA
,
weight loss
Epizyme drug granted approval by FDA for rare cancer
BioPharma Dive
Thu, 01/23/20 - 11:52 pm
Tags:
Epizyme
,
FDA
,
Tazverik
,
Eisai
,
epithelioid sarcoma
FDA Warns of Potential Cancer Risk With Weight Loss Drug
RAPS.org
Tue, 01/14/20 - 09:50 pm
Tags:
FDA
,
Belviq
,
Eisai
,
cancer
FDA clears Eisai’s insomnia drug Dayvigo
Pharmaforum
Mon, 12/30/19 - 11:01 am
Tags:
FDA
,
Eisai
,
Dayvigo
,
insomnia
,
Merck
,
Belsomra
Gilead gets ball rolling on JAKs game in Japan
Endpoints
Mon, 12/30/19 - 10:39 am
Tags:
Gilead Sciences
,
Japan
,
filgotinib
,
Eisai
,
rheumatoid arthritis
Eisai preps for launch with insomnia med Dayvigo after buying out Purdue
Fierce Pharma
Mon, 12/23/19 - 11:36 pm
Tags:
Eisai
,
Purdue
,
FDA
,
drug launches
,
insomnia
,
Dayvigo
Dova Pharma's bet on Eisai castoff spells gold as Sobi spends millions to acquire it
Endpoints
Mon, 09/30/19 - 12:06 pm
Tags:
Dova Pharmaceuticals
,
Eisai
,
Swedish Orphan Biovitrum
,
M&A
ESMO: Merck, Eisai detail Keytruda-Lenvima combo results after triple endometrial cancer OK
Fierce Pharma
Sun, 09/29/19 - 09:37 pm
Tags:
Merck
,
Eisai
,
Keytruda
,
Lenvima
,
endometrial cancer
,
ESMO
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.